RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
28.85
+1.06 (3.81%)
Nov 14, 2025, 4:00 PM EST - Market closed
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $799.46 million as of November 14, 2025. Its market cap has increased by 1,045.24% in one year.
Market Cap
799.46M
Enterprise Value
644.71M
1-Year Change
1,045.24%
Ranking
Category
Stock Price
$28.85
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $799.46M, an increase of 188.99%. That is a compound annual growth rate of 19.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 691.12M | 224.11% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 902.90B |
| Johnson & Johnson | 468.58B |
| AbbVie | 408.80B |
| UnitedHealth Group | 308.52B |
| AstraZeneca | 275.02B |
| Novartis AG | 251.93B |
| Merck & Co. | 227.03B |
| Abbott Laboratories | 222.73B |